Preoperative chemotherapy

Phase 3Small molecule

EEuropean Organisation for Research and Treatment of Cancer - EORTC

Preoperative chemotherapy is one of 80 small molecule programs targeting Adenocarcinoma. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AdenocarcinomaActive, not recruiting

Breast CancerActive, not recruiting

Gastric CancerActive, not recruiting

Retroperitoneal SarcomaActive, not recruiting

AdenocarcinomaPhase 2

Active, not recruiting

Breast CancerPhase 2

Active, not recruiting

Gastric CancerPhase 3

Active, not recruiting

Retroperitoneal SarcomaPhase 3

Active, not recruiting

Competition

Competitive Landscape

2828 competitors in Breast Cancer

#DrugCompanyPhaseTrials

Preoperative chemotherapy

EEuropean Organisation for Research and Treatment of Cancer - EORTC

Phase 3

1 2

Trodelvy

Gilead

Preclinical

37 3

Tykerb

GSK

Preclinical

80 4

Avastin

BBio-Thera Solutions

Preclinical

153 5

Nolvadex

SSan Diego Pacific Oncology & Hematology Associates

Preclinical

78 6

Prolia

Amgen

Preclinical

14 7

Gemzar

GGynecologic Oncology Group

Preclinical

22 8

Voltaren

Novartis

Preclinical

1 9

Blenoxane

Bristol-Myers Squibb

Preclinical

1 10

Lupron

EEastern Cooperative Oncology Group

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2028

Phase 3Recruiting

Retroperitoneal Sarcoma

NCT04031677

Clinical

Trials by Indication[1]

Gastric Cancer1 trial

Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer

Terminated·UUniversity Hospital, Lille·Phase 3·NCT03042169·6 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Preoperative chemotherapy. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Preoperative chemotherapy compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Preoperative chemotherapy. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — European Organisation for Research and Treatment of Cancer - EORTC company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: EEuropean Organisation for Research and Treatment of Cancer - EORTC

Preoperative chemotherapy

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2028

Trials by Indication[1]

Gastric Cancer1 trial

Adenocarcinoma1 trial

Retroperitoneal Sarcoma1 trial

Breast Cancer1 trial

References

Drug Info

Quick Facts

Related News